Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지
DOI QR코드

DOI QR Code

Sinensetin Inhibits Interleukin-6 in Human Mast Cell - 1 Via Signal Transducers and Activators of the Transcription 3 (STAT3) and Nuclear Factor Kappa B (NF-κB) Pathways

  • Received : 2016.05.30
  • Accepted : 2016.10.04
  • Published : 2017.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Sinensetin, a pentamethoxyflavone, is known to exert various pharmacological activities including anti-angiogenesis, anti-diabetic and anti-inflammatory activities. However, its effects on the human mast cell - 1 (HMC-1) mediated inflammatory mechanism remain unknown. To explore the mediator and cellular inflammatory response of sinensetin, we examined its influence on phorbol 12-myristate 13-acetate (PMA) plus A23187 induced inflammatory mediator production in a human mast cell line. In this study, interleukin (IL)-6 production was measured using the enzyme-linked immunosorbent assay and reverse transcription polymerase chain reaction. Sinensetin inhibited PMA plus A23187 induced IL-6 production in a dose-dependent manner as well as IL-4, IL-5 and IL-8 mRNA expression. Furthermore, sinensetin inhibited signal transducer and activator of transcription 3 (STAT3) phosphorylation, suggesting that sinensetin inhibits the production of inflammatory mediators by blocking STAT3 phosphorylation. Moreover, sinensetin was found to inhibit nuclear factor kappa B activation. These findings suggest that sinensetin may be involved in the regulation of mast cell-mediated inflammatory responses.

Keywords

References

  1. Wolff, B.; Burns, A. R.; Middleton, J.; Rot, A. J. Exp. Med. 1998, 188, 1757-1762. https://doi.org/10.1084/jem.188.9.1757
  2. Utgaard, J. O.; Jahnsen, F. L.; Bakka, A.; Brandtzaeg, P.; Haraldsen, G. J. Exp. Med. 1998, 188, 1751-1756. https://doi.org/10.1084/jem.188.9.1751
  3. Baggiolini, M.; Loetscher, P.; Moser, B. Int. J. Immunopharmec. 1995, 17, 103-108. https://doi.org/10.1016/0192-0561(94)00088-6
  4. Ronis, M. J.; Butura, A.; Korourian, S.; Shankar, K.; Simpson, P.; Badeaux, J.; Albano, E.; Ingelman-Sundberg, M.; Badger, T. M. Exp. Biol. Med. 2008, 233, 344-355. https://doi.org/10.3181/0707-RM-203
  5. Conti, P.; Kempuraj, D.; Di Gioacchino, M.; Boucher, W.; Letourneau, R.; Kandere, K.; Barbacane, R. C.; Reale, M.; Felaco, M.; Frydas, S.; Theoharides, T. C. Allergy Asthma Proc. 2002, 23, 331-335.
  6. Kikuchi, T.; Ishida, S.; Kinoshita, T.; Sakuma, S.; Sugawara, N.; Yamashita, T.; Koike, K. Cytokine 2002, 20, 200-209. https://doi.org/10.1006/cyto.2002.2010
  7. Castellani, M. L.; Ciampoli, C.; Felaco, M.; Tete, S.; Conti, C. M.; Salini, V.; De Amicis, D.; Orso, C.; Antinolfi, P. L.; Caraffa, A.; Cerulli, G.; Boscolo, P.; Theoharides, T. C.; Conti, P.; Kepuraj, D. Clin. Invest. Med. 2008, 31, E362-E372. https://doi.org/10.25011/cim.v31i6.4923
  8. Nakahata, T.; Toru, H. Int. J. Hematol. 2002, 75, 350-356. https://doi.org/10.1007/BF02982123
  9. Kim, S. H.; Kim, S. H.; Kim, S. H.; Moon, J. Y.; Park, W. H.; Kim, C. H.; Shin, T. Y. Biol. Pharm. Bull. 2006, 29, 494-498. https://doi.org/10.1248/bpb.29.494
  10. Theoharides, T. C.; Kempuraj, D.; Tagen, M.; Conti, P.; Kalogeromitros, D. Immunol. Rev. 2007, 217, 65-78. https://doi.org/10.1111/j.1600-065X.2007.00519.x
  11. Ihle, J. N. Cell 1996, 84, 331-334. https://doi.org/10.1016/S0092-8674(00)81277-5
  12. Takeda, K.; Noguchi, K.; Shi, W.; Tanaka, T.; Matsumoto, M.; Yoshida, N.; Kishimoto, T.; Akira, S. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 3801-3804. https://doi.org/10.1073/pnas.94.8.3801
  13. Zhong, Z.; Wen, Z.; Darnell, J. E. Jr. Science 1994, 264, 95-98. https://doi.org/10.1126/science.8140422
  14. Yang, X. O.; Panopoulos, A. D.; Nurieva, R.; Chang, S. H.; Wang, D.; Watowich, S. S.; Dong, C. J. Biol. Chem. 2007, 282, 9358-9363. https://doi.org/10.1074/jbc.C600321200
  15. Laavola, M.; Nieminen, R.; Yam, M. F.; Sadikun, A.; Asmawi, M. Z.; Basir, R.; Welling, J.; Vapaatalo, H.; Korhonen, R.; Moilanen, E. Planta Med. 2012, 78, 779-786. https://doi.org/10.1055/s-0031-1298458
  16. Shin, H. S.; Kang, S. I.; Yoon, S. A.; Ko, H. C.; Kim, S. J. Biosci. Biotechnol. Biochem. 2012, 76, 847-849. https://doi.org/10.1271/bbb.110908
  17. Kishimoto, T. Annu. Rev. Immunol. 2005, 23, 1-21. https://doi.org/10.1146/annurev.immunol.23.021704.115806
  18. Quintanilla-Martinez, L.; Kremer, M.; Specht, K.; Calzada-Wack, J.; Nathrath, M.; Schaich, R.; Hofler, H.; Fend, F. Am. J. Pathol. 2003, 162, 1449-1461. https://doi.org/10.1016/S0002-9440(10)64278-2
  19. Akira, S.; Nishio, Y.; Inoue, M.; Wang, X. J.; Wei, S.; Matsusaka, T.; Yoshida, K.; Sudo, T.; Naruto, M.; Kishimoto, T. Cell 1994, 77, 63-71. https://doi.org/10.1016/0092-8674(94)90235-6
  20. Darnell, J. E. Jr.; Kerr, I. M.; Stark, G. R. Science 1994, 264, 1415-1421. https://doi.org/10.1126/science.8197455
  21. Murray, P. J. J. Immunol. 2007, 178, 2623-2629. https://doi.org/10.4049/jimmunol.178.5.2623
  22. Hodge, D. R.; Hurt, E. M.; Farrar, W. L. Eur. J. Cancer 2005, 41, 2502-2512. https://doi.org/10.1016/j.ejca.2005.08.016
  23. Lee, M. M.; Chui, R. K.; Tam, I. Y.; Lau, A. H.; Wong, Y. H. J. Immunol. 2012, 189, 5266-5276. https://doi.org/10.4049/jimmunol.1103359
  24. Fleischer, A.; Ghadiri, A.; Dessauge, F.; Duhamel, M.; Rebollo, M. P.; Alvarez-Franco, F.; Rebollo, A. Mol. Immunol. 2006, 43, 1065-1079. https://doi.org/10.1016/j.molimm.2005.07.013
  25. Lappas, M.; Permezel, M.; Georgiou, H. M.; Rice, G. E. Biol. Reprod. 2002, 67, 668-673. https://doi.org/10.1095/biolreprod67.2.668
  26. Ivanenkov, Y. A.; Balakin, K. V.; Tkachenko, S. E. Drugs in R&D 2008, 9, 397-434. https://doi.org/10.2165/0126839-200809060-00005

Cited by

  1. Sinensetin: An Insight on Its Pharmacological Activities, Mechanisms of Action and Toxicity vol.11, pp.None, 2017, https://doi.org/10.3389/fphar.2020.553404